Vimarsana
Biggest News Aggregation in the World

Page 6 - Philipp Mathieu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philipp Mathieu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philipp Mathieu Today - Breaking & Trending Today

Immunovia realigning Swedish operations with strategic priorities and its focus on the US commercialization of the IMMray™ PanCan-d test - Vimarsana News

Immunovia realigning Swedish operations with strategic priorities and its focus on the US commercialization of the IMMray™ PanCan-d test

/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first blood test dedicated to the early detection...

Immunovia Reducing Headcount, Realigning to Focus on Pancreatic Cancer Test Commercialization - Vimarsana News

Immunovia Reducing Headcount, Realigning to Focus on Pancreatic Cancer Test Commercialization

The firm said it will reduce in-house R&D staff from its operations in Lund, Sweden, as it focuses on bringing the ImmRay PanCan-d test to the US market.

Source: 360dx.com
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market - Vimarsana News

Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market

Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market - read this article along with other careers information, tips and advice on BioSpace

Immunovia AB: Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray PanCan-d test in the US market - Vimarsana News

Immunovia AB: Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray PanCan-d test in the US market

LUND, Sweden, Jan. 17, 2023 /PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company that has launched the world's first blood test dedicated to the early detection of pancreatic

Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market - Vimarsana News

Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market

/PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company that has launched the world's first blood test dedicated to the early detection...